Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117821355A reveals efficient enzymatic synthesis for ferulic acid. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel one-pot Friedel-Crafts route for 6-methoxy-1-tetralone. High yield, low cost, scalable steroid intermediate manufacturing avoiding toxic chromium reagents.
Patent CN107445795A reveals a visible-light photocatalytic method for fluorinated aryl blocks. Enables cost reduction in agrochemical manufacturing and high-purity supply.
Patent CN114437169B reveals a green, solvent-free ball milling method for synthesizing high-purity drospirenone intermediates, offering significant cost and supply chain advantages.
Patent CN102093166B details a scalable asymmetric synthesis of (S)-trans-1-yn-4-en-eicosan-3-ol with >97% ee, offering a reliable alternative to natural extraction for pharmaceutical applications.
Patent CN103073483A reveals a safe, high-yield route for Mepivacaine using formic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN113683571B reveals a safe, scalable route for 2-methyl-5-bromopyrimidine, replacing hazardous organometallics with stable ester substitution for reliable pharmaceutical intermediate supply.
Advanced synthesis of Peramivir via CN102372657B. Replaces expensive PtO2 and toxic HgCl2. Cost-effective, scalable API intermediate manufacturing solution.
Patent CN112300085A reveals a green, base-mediated alkenylation method using alcohols and air, offering significant cost reduction and purity advantages for pharmaceutical manufacturing.
Patent CN101186600B details a mild, non-phosphorus cyclization for flavonoids using BTC and DMF. This method offers high yields and reduced environmental impact for pharmaceutical manufacturing.
Patent CN111559976B reveals a catalyst-free, solvent-free method for heteroaryl sulfide synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel patent CN109651202A enables safe carbamate synthesis using CO2. Reduces toxicity risks and simplifies supply chain for pharmaceutical intermediates.
Novel three-step nucleophilic substitution route for Adefovir using ethylene oxide and magnesium tert-butoxide, offering high purity and industrial scalability.
Patent CN113402472B details a novel route for sulfentrazone intermediates, bypassing 2,4-dichloroaniline to offer significant cost reduction and supply chain stability for agrochemical manufacturers.
Novel method for Adefovir synthesis using adenine and ethylene oxide, offering high purity and cost-effective industrial scalability for antiviral manufacturers.
Patent CN115806510B reveals a cost-effective two-step synthesis for high-purity Cariprazine intermediates, offering significant supply chain advantages for API manufacturers.
Novel POCl3-mediated cyclization yields high-purity thiadiazole intermediates. Streamlined process reduces costs for pharmaceutical manufacturing supply chains.
Novel synthetic method for Inavolisib intermediate GDC-0077 via etherification and cyclization. Offers high purity, scalable production, and cost reduction for pharmaceutical supply chains.
Patent CN102702228A reveals a novel one-pot method for Sulbactam from 6-APA, replacing hazardous bromine with HBr to reduce pollution and improve yield.
Patent CN114230653B reveals a novel fragment coupling method for Chlorotoxin, achieving >99% purity. Discover cost-effective manufacturing strategies for this tumor-targeting peptide intermediate.